Survey of Global Investigative Sites, Provide Your Input Today
Survey of Global Investigative Sites
The Tufts Center for Drug Development is conducting a study in collaboration with Applied Clinical Trials to understand how the global site landscape is changing and what areas are most challenging to investigative sites. As clinical trials become increasingly more global, we are undertaking a survey to understand how globalization is affecting investigative sites.
We want to know investigator and study coordinator opinions and experiences for an article that will appear in our June 2010 issue. The more responses we receive the better, and your feedback is highly valued by sponsors. Sponsors will use the results of this survey to understand how they can better support your site, and others around the world.
Please take a moment to complete this important survey developed by the Tufts Center for the Study of Drug Development, and please forward this email to an investigator or site coordinator who might be interested.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
